Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ACCENDRA HEALTH INC/VA/ entered into Commitment and Consent Letter with certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement (effective 2026-05-11).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement
- Effective
- 2026-05-11
Exact text from the filing
On May 11, 2026, Accendra Health, Inc. (the “ Company ”) entered into a Commitment and Consent Letter (the “ Commitment Letter ”) with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 (the “ 2029 Notes ”) and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding approximately all of the outstanding principal amount of the 2029 Notes and approximately 83% of the outstanding principal amount of the 2030 Notes as of May 11, 2026 and (ii) lenders under the Company’s existing Term Loan Credit Agreement (as defined below) (collectively, the “ Commitment and Consenting Parties ” and each, a “ Commitment and Consenting Party ”), (b) certain lenders under the Company’s existing Term Loan Credit Agreement consenting solely with respect to the Term B-1 Term Loan Consent (as defined below) (the “ Term B-1 Term Loan Consenting Parties ”) and (c) all lenders under the Company’s Exist
View on SEC.gov